On ECHEMI
Home > Drugs > Henan Shuanghe Huali Pharmaceutical Co., Ltd.
Henan Shuanghe Huali Pharmaceutical Co., Ltd.
  • Founded in:

    2011-09-30
  • Country:

    China China
  • Address:

    No. 369 Qinggong Road, Pingdingshan City
  • Tax NO.:

    91410400582895296J
  • Registered Funds:

    118 million yuan
  • Website:

  • Email:

Related Drugs
Compound Amino Acid Injection (6AA)
This product is a compound preparation, a sterile aqueous solution prepared from 18 kinds of amino acids and sorbitol.
Name Description Content CAS NO. Registered Holders
L-tert-Leucine

When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.

More

When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.

20859-02-3 0
Sorbitol

When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.

More

When there is sufficient energy supply, amino acid infusion can enter tissue cells, participate in protein anabolism, obtain positive nitrogen balance, and generate enzymes, hormones, antibodies, and structural proteins to promote tissue healing and restore normal physiological functions.

50-70-4 23
Glucose injection
The main component of this product is glucose. Its chemical name is D-(+)-pyranose glucose-hydrate.
Name Description Content CAS NO. Registered Holders
GLUCOSE

It is one of the main sources of heat for the human body. Each gram of glucose can produce 4 calories (16.7 kJ) of heat energy, so it is used to supplement heat. Treat hypoglycemia. When glucose and insulin are intravenously infused together, potassium ions are required for the synthesis of glycogen, so potassium ions enter the cells and the blood potassium concentration decreases, so it is used to treat hyperkalemia. Rapid intravenous push of hypertonic glucose injection has a tissue dehydrating effect and can be used as a tissue dehydrating agent. In addition, glucose is the main substance for maintaining and regulating the osmotic pressure of peritoneal dialysis fluid.

More

It is one of the main sources of heat for the human body. Each gram of glucose can produce 4 calories (16.7 kJ) of heat energy, so it is used to supplement heat. Treat hypoglycemia. When glucose and insulin are intravenously infused together, potassium ions are required for the synthesis of glycogen, so potassium ions enter the cells and the blood potassium concentration decreases, so it is used to treat hyperkalemia. Rapid intravenous push of hypertonic glucose injection has a tissue dehydrating effect and can be used as a tissue dehydrating agent. In addition, glucose is the main substance for maintaining and regulating the osmotic pressure of peritoneal dialysis fluid.

58367-01-4 15
Dextran 40 Glucose Injection
This product is a sterile aqueous solution of dextran 40 and 5% glucose. Its average molecular weight is 40,000.
Name Description Content CAS NO. Registered Holders
Dextran

Blood volume expander, increases plasma colloidal osmotic pressure, increases blood volume, raises and maintains blood pressure; improves microcirculation and prevents thrombosis; has osmotic diuretic effect; has strong antigenicity and may induce allergic reactions.

More

Blood volume expander, increases plasma colloidal osmotic pressure, increases blood volume, raises and maintains blood pressure; improves microcirculation and prevents thrombosis; has osmotic diuretic effect; has strong antigenicity and may induce allergic reactions.

9004-54-0 16
GLUCOSE

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect. This product has strong antigenicity. Since there are bacteria that produce this product in the normal intestine, some patients will have allergic reactions even after the first injection of this product. Mainly skin and mucous membrane allergic reactions.

5% 58367-01-4 15
Betahistine Hydrochloride and Sodium Chloride Injection
Betahistine hydrochloride sodium chloride. Its chemical name is: N-methyl-2-pyridineethylamine dihydrochloride. Molecular formula: C8H12N22HC1
Name Description Content CAS NO. Registered Holders
Betahistine dihydrochloride

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

5579-84-0 20
Sodium chloride

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

More

This product is a diamine oxidase inhibitor, which has a more obvious dilating effect on cerebrovascular and cardiovascular systems, especially on the vertebral artery system, significantly increasing the blood flow of the heart, brain and peripheral circulation, improving blood circulation, and lowering systemic blood pressure. In addition, it can increase the blood flow of the cochlea and anterior base, thereby eliminating inner ear vertigo, tinnitus and ear closure, and can also increase capillary permeability, promote the absorption of extracellular fluid, and eliminate lymphatic edema; it can counteract the vasoconstrictive effect of catecholamines and lower arterial pressure, and has the effect of inhibiting plasma coagulation and ADP-induced platelet aggregation, can prolong the time of thrombosis in vitro in rats, and has a slight diuretic effect.

7647-14-5 43
Mannitol injection
The main ingredient of this product and its chemical name: D-mannitol.
Name Description Content CAS NO. Registered Holders
D-Mannitol

It produces direct pharmacological effects through hypertonic dehydration, eliminating brain edema, reducing brain water content, and lowering intracranial pressure; it is not metabolized in the body, and after glomerular filtration, it is rarely reabsorbed in the renal tubules, playing an osmotic diuretic role. 1g of mannitol can produce an osmotic concentration of 5.5mOsm, and injection of 100g of mannitol can transfer 2000ml of intracellular water to the extracellular space, and excrete 50g of urinary sodium.

More

It produces direct pharmacological effects through hypertonic dehydration, eliminating brain edema, reducing brain water content, and lowering intracranial pressure; it is not metabolized in the body, and after glomerular filtration, it is rarely reabsorbed in the renal tubules, playing an osmotic diuretic role. 1g of mannitol can produce an osmotic concentration of 5.5mOsm, and injection of 100g of mannitol can transfer 2000ml of intracellular water to the extracellular space, and excrete 50g of urinary sodium.

69-65-8 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.